Using human stem cells to model CF airway disease, development and identify new therapies

Speaker #1: Zoe Ngan: Using iPSC-derived lung models to predict patient-specific CFTR modulator responses Speaker #2: Elena Huang: Targeting CFTR transcription as a complimentary treatment for CF production mutants Speaker #3: Henry Quach: Delineating a regulatory role of CFTR in lung development and disease